Description
| Sacubitril is a prodrug and first-in-class neprilysin inhibitor. It is administered exclusively in combination with the angiotensin II receptor blocker (ARB) valsartan. Sold under the brand name Entresto, this combination is used to treat chronic heart failure and reduce the risk of cardiovascular death. |
Reviews
There are no reviews yet.